Receptor-mediated oxidative stress in murine cerebellar neurons is accompanied by phosphorylation of MAP (ERK 1/2) kinase

Current Aging Science

Volumn 5, Issue 3, 2012, Pages 225-230

  Rybakova, Yulia ^a   Akkuratov, Evgeny ^b   Kulebyakin, Konstantin ^b   Brodskaya, Olga ^b   Dizhevskaya, Antonina ^b   Boldyrev, Alexander ^b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

Author keywords

Carnosine; ERK 1 2; Homocysteine; Na K ATPase; Neurons; NMDA; Ouabain; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CARNOSINE; DIZOCILPINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; HOMOCYSTEINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OUABAIN; REACTIVE OXYGEN METABOLITE;

ADAPTATION; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL ACTIVATION; CELL PROTECTION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; INTRACELLULAR SIGNALING; MOLECULAR DYNAMICS; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION;

EID: 84874924907     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609811205030009     Document Type: Article

References (42)

1. Guyton KZ, Gorospe M, Kensler TW, Holbrook NJ. Mitogenactivated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: implications for cellular survival and tumor promotion. Cancer Res 1996 1; 56(15): 3480-5.
2. Chu CT, Levinthal DJ, Kulich SM, Chalovich EM, DeFranco DB. Oxidative neuronal injury. The dark side of ERK1/2. Eur J Biochem 2004; 271(11): 2060-66.
3. Klafki HW, Lewczuk P, Kamrowski-Kruck H, et al. Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form. J Alzheimer's Dis 2009; 18(3): 613-22.
4. Zhu X, Lee HG, Raina AK, Perry G, Smith MA. The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 2002; 11(5): 270-81.
5. Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 2010; 1802(4): 396-05.
6. Garthwaite J. NMDA receptors, neuronal development, and neurodegeneration. New York: Oxford University Press. 1994.
7. Alford S, Brodin L The role of NMDA receptors in synaptic integration and the organization of motor patterns. New York: Oxford University Press. 1994.
8. Morris RGM, Davis M. The role of NMDA receptors in learning and memory. 2nd ed. New York: Oxford University Press. 1994.
9. Bear MF, Malenka RC. Synaptic plasticity: LTP and LTD. Curr Opin Neurobiol 1994; 4(3): 389-99.
10. Fagni L, Bossu JL, Bockaert J. Inhibitory effects of dihydropyridines on macroscopic K currents and on the largeconductance Ca-activated K-channel in cultured cerebellar granule cells. Pflugers Arch 1994; 429(2): 176-82.
11. Gunasekar PG, Kanthasamy AG, Borowitz JL, Isom GE. NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death. J Neurochem 1995; 65(5): 2016-21.
12. Urushitani M, Nakamizo T, Inoue R, Sawada H, Kihara T, Honda K, Akaike A, Shimohama S. N-methyl-D-aspartate receptormediated mitochondrial Ca overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca influx. J Neurosci Res 2001; 63(5): 377-87.
13. Hidalgo C, Núñez MT. Calcium, iron and neuronal function. IUBMB Life 2007 (4-5): 280-5.
14. Zigmond MJ. Triggering endogenous neuroprotective mechanisms in Parkinson's disease: studies with a cellular model. J Neural Transm Suppl. 2006; (70): 439-42.
15. Boldyrev AA. Molecular mechanisms of homocysteine toxicity. Biochemistry (Moscow) 2009; 74(6): 589-98.
16. Makhro V, Bulygina ER, Boldyrev AA. Effects of Homocysteine and Homocysteinic Acid on cerebellar granule cells. Neurochem J 2007; 1(2): 127-32.
17. Kim WK, Pae YS. Involvement of N-methyl-D-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture. Neurosci Lett 1996; 216(2): 117-20.
18. Boldyrev AA. Why Homocysteine Is a Risk Factor of Neurodegenerative Diseases. Neurochem J 2007; 1(1): 14-20.
19. Cantley LC. Structure and mechanism of the Na/K-ATPase. Curr Top Bioenerg 1981; 2: 201-37.
20. Monteith GR, Blaustein MP. Different effects of low and high dose cardiotonic steroids on cytosolic calcium in spontaneously active hippocampal neurons and incultured glia. Brain Res 1998; 795(1-2):325-40.
21. Kometiani P, Li J, Gnudi L, Kahn BB, Askari A, Xie Z. Multiple signal transduction pathways link Na/K-ATPase to growth-related genes in cardiac myocytes. J Biol Chem 1998; 273: 15249-56.
22. Xie Z, Askari A. Na/K-ATPase as a signal transducer. Eur J Biochem 2002; 269: 2434-39.
23. Boldyrev AA, Bulygina ER, Carpenter D, Schoner W. Glutamate Receptors Communicate with Na/K-ATPase in Rat Cerebellum Granule Cells. J Molecular Neurosci 2003; 3(21): 213-22.
24. Karpova LV, Akkuratov EE, Bulygina ER, Boldyrev AA. Both Ouabain-Sensitive and Ouabain-Resistant Isoforms of Na/KATPase in Cerebellar Granule Cells Control MAP Kinase Activity. Membr Cell Biol 2008; 2(2): 156-60.
25. Bagrov AY, Shapiro JI, Fedorova OV. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev 2009; 61(1): 9-38.
26. Streck EL, Matte C, Vieira PS, Rombaldi F, Wannmacher CM, Wajner M, Wyse AT. Reduction of Na/K-ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia. Neurochem Res 2002; 27(12): 1593-98.
27. Bersier MG, Pena C, de Lores Arnaiz RG. The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na/KATPase inhibitor. Neurochem Res 2008; 33(1): 66-72.
28. Bulygina ER, Boldyrev AA. Demonstration of differences in the action of several metabotropic and ionotropic glutamate agonists on intracellular reactive oxygen species and the Na-pump. J Alzheimer's Disease 2004; 5: 6.
29. Bulygina ER, Lyapina LY, Boldyrev AA. Activation of glutamate receptors inhibits Na/K-ATPase of cerebellum granule cells. Biochem 2002; 67(9): 1001-5.
30. Boldyrev AA. Carnosine: biological role and prospects for use in medicine. Biochem 1992; 57(9): 1302-10.
31. Boldyrev AA, Severin SE. The histidine-containing dipeptides, carnosine and anserine: distribution, properties and biological significance. Adv Enzyme Regul 1990; 30: 175-94.
32. Abe R, Shimoseqawa T, Moriizumi S, et al. Lipopolysaccharide induces manganese superoxide dismutase in the rat pancreas: its role in caerulein pancreatitis. Biochem Biophys Res Commun 1995; 217(3): 1216-22.
33. Boldyrev AA, Johnson P, Wei Y, Tan Y, Carpenter DO. Carnosine and taurine protect rat cerebellar granular cells from free radical damage. Neurosci Lett 1999; 263(2-3):169-72.
34. Boldyrev AA, Stvolinsky SL, Fedorova TN, Suslina ZA. Carnosine as a natural antioxidant and geroprotector: from molecular mechanisms to clinical trials. Rejuv Res 2010; 13(2-3): 156-58.
35. Shen Y, Hu WW, Chen Z. Carnosine and diseases of central nervous system. Zhejiang Da Xue Xue Bao Yi Xue Ban 2007; 36(2): 199-203.
36. Perry G, Nunomura A, Hirai K, et al. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med 2002; 33(11): 1475-9.
37. Boldyrev A, Bulygina E, Makhro A. Glutamate receptors modulate oxidative stress in neuronal cells. Neurotox Res 2004; 6(7-8): 581-7.
38. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80(2): 179-85.
39. Poddar R, Paul S. Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J Neurochem 2009; 110(3): 1095-06.
40. Segal RA, Greenberg ME. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 1996; 19: 463-89.
41. Glotin AL, Calipel A, Brossas JY, Faussat AM, Treton J, Mascarelli F. Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells. Invest Ophthalmol Vis Sci 2006; 47(10): 4614-23.
42. Karpova LV, Bulygina ER, Boldyrev AA. Different neuronal Na/K-ATPase isoforms are involved in diverse signaling pathways. Cell Biochem Funct 2010; 28(2): 135-41.